Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11229702 High concentration formulations of adalimumab

Patent 11229702 was granted and assigned to Coherus BioSciences on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Article (+457 characters)
Article

Patent abstract

The present invention relates to aqueous pharmaceutical compositions comprising a high concentration (i.e., greater than 50 milligrams per milliliter) of adalimumab (including antibody proteins considered or intended as “biosimilar” or “bio-better” variants of commercially available adalimumab) suitable for long-term storage, and methods of manufacture of the compositions; methods of their administration; and articles containing the same.

Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1122970200
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 23 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 15 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11576971 Method of filling a container with no headspace
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 22 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11229702
Edits on 27 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Jan, 2022
Edits made to:
Infobox (+14 properties)
‌

 US Patent 11229702 High concentration formulations of adalimumab

Infobox
Is a
Patent
Patent
Patent applicant
Coherus BioSciences
Coherus BioSciences
Current assignee
Coherus BioSciences
Coherus BioSciences
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11229702
Date of patent
January 25, 2022
Patent application number
15337519
Date Filed
October 28, 2016
Patent citations
‌
US Patent 10155039 Stable aqueous formulations of adalimumab
‌
US Patent 10159732 Stable aqueous formulations of adalimumab
‌
US Patent 10159733 Stable aqueous formulations of adalimumab
‌
US Patent 10195275 Stable aqueous formulations of adalimumab
‌
US Patent 10207000 Stable aqueous formulations of adalimumab
Patent primary examiner
‌
Yunsoo Kim

Find more entities like US Patent 11229702 High concentration formulations of adalimumab

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo